Pay in 4 interest-free payments of $7.32 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Around 4 in 10 participants were able to stop at least one blood pressure medicine during treatment
Contraception Counseling : Women using oral hormonal contraceptives should use an additional non-hormonal contraceptive method for 4 weeks after initiating tirzepatide and for 4 weeks after each dose increase
For someone starting at 180 lbs, that represents 13 to 18 lbs lost in just three months
For personalized insight into your metabolic predispositions, PlexusDx offers the Precision Peptide Genetic Test ($99 after your first month), which maps variants in genes like FTO rs9939609 and MC4R rs17782313 that influence hunger regulation and energy expenditure
In June 2025, Eli Lilly reported Phase III ACHIEVE-1 Survodutide (BI 456906): Boehringer Ingelhium Survodutide (BI 456906) is a GCGR/GLP1 dual agonist being developed by Boehringer Ingelhium
Lancet 388 , 776786 (2016)
US$ 22.00
US$ 24.68
US$ 23.72
US$ 29.70
US$ 29.54
US$ 26.21
US$ 23.33
US$ 23.98
